Phase II Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 13 Jan 2017
Price : $35 *
At a glance
- Drugs Iodine-131 tositumomab (Primary) ; Tositumomab (Primary) ; Cyclophosphamide; Prednisone; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 24 Apr 2013 Primary endpoint amended as reported by ClinicalTrials.gov record.
- 20 Aug 2012 New trial record